As of July 1, 2024, there are 105 Ozempic, Wegovy, and Rybelsus gastroparesis cases pending in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
One antioxidant nutrient with a significant body of literature in support of its antioxidant effects is carnitine [25, 26] which is associated with a reduction in xanthine oxidase activity [27] and known to possess free-radical scavenging activity [28]
For many patients, there is a transition: Phase 1: Correct Improve insulin resistance Reduce inflammation Initiate weight loss Phase 2: Stabilize Support muscle and metabolism Begin lowering the dose Phase 3: Maintain / Optimize Lower-dose or microdosing approach (when appropriate) Focus on long-term metabolic health At lower doses, GLP-1 medications may continue to support the bodynot just for weight loss, but for overall metabolic function
@ADA_DiabetesPro diabetesjournals.org/care/article/d Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the @AmDiabetesAssn
If animal's condition worsens or does not improve, contact your veterinarian